- In Search of America's ‘Hottest Forecasters’
- Dow vs. S&P 500: Which is a Better Investment?
- Mick Fleetwood on the MP3 ‘Dumbing Down’ of Music
- Avis on the Road to Strong Growth: Analyst
- Private Homebuilders: Dead Men Walking
- LinkedIn’s Growth Is Already Priced In: Analyst
- The Real Reason Behind Bank of America’s Rally
- 5 Hedge Funds’ Top Stocks Soar After 2011 Rout
- This Valentine’s Day Love Is Served on a Silver Platter
- Greek Cabinet Approves EU, IMF Bailout Bill
- We're Not Greece: Italian Prime Minister Monti
- Private Homebuilders in the US: Dead Men Walking
- Dividend Payout Could Hit Record Amount This Year
- With Investors So Bullish, Stock Pullback Must Be Ahead
- Obama Likely to Call for Cutting Top Corporate Tax Rate
- New York Fashion Week Fall 2012
- NetNet: Why Saving Greece Could Destroy the World
- My Funny Valentine: When Love and the Fed Collide
MOST SHARED
- We're Not Greece: Italian Prime Minister Monti
- Obama Likely to Call for Cutting Top Corporate Tax Rate
- To Play Senate Cybersecurity Bill, Cramer Likes Fortinet Stock
- Greek Cabinet Approves EU, IMF Bailout Bill
- Special Feature: Wall Street History - How Wall Street Got Its Name
- How to Trade the Turmoil in Greece
- Private Homebuilders: Dead Men Walking
- Why Cramer Likes Select Comfort Over Tempur-pedic Stock
- Cramer: 10 Earnings to Watch Next Week
- Lightning Round: Trina Solar, Zoltek, Affymax and More
Pfizer's McKinnell - The $200 Million Dollar Man
Text Size 
Reporter
 |
Pfizer [PFE
Loading...
()
]fired McKinnell as CEO last July and stripped him of his chairmanship 2 months earlier than expected this week. But according to this SEC filing posted on the web after the market close yesterday, McKinnell is none the worse for the wear.
The company he worked at for nearly 4 decades and ran for about 5 years says it won't see revenue growth until at least 2009. (It's cutting billions of dollars in costs, letting thousands of employees go - and that was before the loss of a key developmental drug earlier this month, so it could even get worse.) But Hank McKinnell will be sitting pretty. Pfizer shares fell about 40% on McKinnell's watch. They've risen about 3 bucks since around the time he was ousted.
Pfizer says McKinnell is getting an $82 million pension. (He can get one big fat check or draw a whole bunch of relatively smaller ones over several years.) He has $78 million in deferred compensation coming to him. That's money he earned but let ride for example in Pfizer stock.
And then McKinnell will get another $39 million in severance bonuses and other cash and stock including compensation for vacation time he did not use. The total value of his additional time on the clock - more than $300,000 for a grand total of $199 million.
In a research note to clients this morning Miller Tabak Healthcare Analyst Les Funtleyder figures the exit package works out to "A little over $2 million for every billion dollars in market cap lost during his tenure."
He says "Though this will receive some media attention, we view this as more annoying than material."
A Pfizer spokesman says the company is fulfilling its legal obligation to honor the terms of McKinnell's contract which was signed in 2001 - what he called a "Different time in the company's history". He says he doesn't know if McKinnell has told Pfizer how he wants his money, whether he'll take it all at once or spread it out.
- Marketing clichés aside, sometimes diamonds are for investing.
- The ‘Fast Money’ traders weigh in on fashion related stocks from apparel to footwear.
- This list of the 10 most active cities for speed traps was compiled by Trapster.com. See if your town is there.
- This Valentine’s Day should prove a love fest for restaurants, as many couples will be dining out.
- Here’s a look at Westminster Kennel Club’s most successful breeds—and how much they cost.
- What kind of homes do celebrity couples share? Here’s our updated list. Take a look.
Data is a real-time snapshot *Data is delayed at least 15 minutes
